Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Research Scholarships - Master's program

University of Toronto

$27,000.00

Investigating Alzheimer’s disease pathogenesis using vascularized immunocompetent cerebral organoids

FY 2025-26

Summary
Alzheimer’s disease (AD) is the most common cause of dementia and affects millions of people worldwide. Current models of AD fail to accurately capture human-specific disease conditions. This is partly because cells grown in a flat 2D layer cannot reproduce the 3D architecture and brain complexity. Furthermore, animal models are unable to accurately recapitulate specific physiological features unique to humans. These gaps in current models pose a major challenge in developing effective therapies. To address this, we aim to develop human-based models of AD using stem cell technology. Induced pluripotent stem cells (iPSCs) will be used to create three-dimensional brain-like tissue, called human cerebral organoids (hCOs). These hCOs will include neurons, immune cells (microglia), and blood vessels, allowing them to mimic key features of the human brain. Combinations of healthy and AD-mutant neurons, microglia, and vascular cells will be assembled into hCOs. This will allow us to study how each cell type contributes to AD onset and progression. By establishing a human-specific model of AD, this project aims to provide insight into the key events that drive neurodegeneration. Ultimately, these findings will improve our understanding of AD and support the development of more effective therapeutic strategies for aging populations.
Program
Master's Award: Canada Graduate Research Scholarships - Master's program
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
573140
Name
Chauhan Mahnoor
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating Alzheimer’s disease pathogenesis using vascularized immunocompetent cerebral organoids
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Research Scholarships - Master's program
Keyworddelim
Alzheimer'S Disease (Ad); Amyloid-B (Ab); Cerebral Organoids; Disease Modelling; Immunocompetent Organoids; Induced Pluripotent Stem Cells (Ipscs); Microglia; Neurodegenerative Disorders; Neuroinflammation; Vascular Dysfunction
Abstract
Alzheimer’s disease (AD) is the most common cause of dementia and affects millions of people worldwide. Current models of AD fail to accurately capture human-specific disease conditions. This is partly because cells grown in a flat 2D layer cannot reproduce the 3D architecture and brain complexity. Furthermore, animal models are unable to accurately recapitulate specific physiological features unique to humans. These gaps in current models pose a major challenge in developing effective therapies. To address this, we aim to develop human-based models of AD using stem cell technology. Induced pluripotent stem cells (iPSCs) will be used to create three-dimensional brain-like tissue, called human cerebral organoids (hCOs). These hCOs will include neurons, immune cells (microglia), and blood vessels, allowing them to mimic key features of the human brain. Combinations of healthy and AD-mutant neurons, microglia, and vascular cells will be assembled into hCOs. This will allow us to study how each cell type contributes to AD onset and progression. By establishing a human-specific model of AD, this project aims to provide insight into the key events that drive neurodegeneration. Ultimately, these findings will improve our understanding of AD and support the development of more effective therapeutic strategies for aging populations.
Competitiondate
202512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chauhan, Mahnoor
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~